Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency

• Status: Completed
• Trial end date: 2006-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate long-term safety of growth hormone replacement in adult patients with growth hormone deficiency

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Hormones

Criteria

Inclusion Criteria:

• Having completed the preceding long-term study of growth hormone replacement in adult patients diagnosed with growth hormone deficiency.

• Other pituitary hormone deficiencies being replaced if appropriate

Exclusion Criteria:

• With severe impairments of cardiac, pulmonary, renal or hepatic functions

• With severe psychological disorders

• With malignant cancer

• With hypertension uncontrolled

• With diabetes mellitus